The EsophyX® is a new device that has been available for commercial use in the UK for about a year. It makes use of a technique called Transoral incisionless fundoplication (TIF).
The EsophyX® forms and fastens tissue folds to create a valve, with the intention of recreating the natural anatomy. Although the staple is placed with a trans-oral procedure (not surgery), the device is still implanted under general anaesthetic.
According to a study published in March 2009*, the procedure proved an effective treatment for most patients, with over 50% reporting an improvement in their GERD questionnaire score. Most patients also saw their heartburn eliminated and 71% were able to eliminate their daily PPI therapy.
- The study comprised only 14 patients
- There is no long term follow up data
When viewing the results against those for the LINX™, we consider the LINX™ to represent the better option for those patients who are eligible.